Precision BioSciences enters new exec employment agreements with enhanced severance

PRECISION BIOSCIENCES INC

CEO Michael Amoroso: 18-month salary severance, 1.5x target bonus, 25-month equity acceleration.
CFO Alex Kelly, GC Dario Scimeca, CRO Jeff Smith: 12-month salary severance, 1x target bonus, 13-month equity acceleration.
Enhanced COBRA premium reimbursement and extended option exercise periods for all four executives.
Agreements effective Jan 22, 2024, supersede prior employment agreements from September 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.